Health Catalyst Inc (NASDAQ:HCAT) price on Thursday, July 03, remained unchanged to $4.06.
A look at the stock’s price movement, the close in the last trading session was $4.06, moving within a range at $4.01 and $4.12. The beta value (5-Year monthly) was 1.529. Turning to its 52-week performance, $9.24 and $3.49 were the 52-week high and 52-week low respectively. Overall, HCAT moved 0.50% over the past month.
Health Catalyst Inc’s market cap currently stands at around $282.58 million, with investors looking forward to this quarter’s earnings report slated for on 2025-May-07.
Turning to the stock’s technical picture we see that short term indicators suggest on average that HCAT is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 8 recommend HCAT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
HCAT’s current price about 4.54% and 2.96% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 57.35, while 7-day volatility ratio is 5.53% and 5.94% in the 30-day chart. Further, Health Catalyst Inc (HCAT) has a beta value of 1.46. Analysts have given the company’s stock an average 52-week price target of $5, forecast between a low of $5 and high of $7. Looking at the price targets, the low is -23.15% off current price level while to achieve the yearly target high, price needs to move -72.41%. Nonetheless, investors will most likely welcome a -23.15% jump to $5 which is the analysts’ median price.
If we refocus on Health Catalyst Inc (NASDAQ:HCAT), historical trading data shows that trading volumes averaged 0.73 over the past 10 days and 593.15K over the past 3 months. The company’s latest data on shares outstanding shows there are 69.48 million shares.
The 4.84% of Health Catalyst Inc’s shares are in the hands of company insiders while institutional holders own 79.77% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 3.24 million on 2025-06-13, giving us a short ratio of 5.79. The data shows that as of 2025-06-13 short interest in Health Catalyst Inc (HCAT) stood at 531.0 of shares outstanding, with shares short rising to 3.21 million registered in 2025-05-15. Current price change has pushed the stock -33.11% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HCAT stock continues to rise going into the next quarter.